APAMITAsia-Pacific Acute Myocardial Infarction Trial. A trial comparing safety and efficacy of combined tPA and abciximab therapy and rescue angioplasty versus abciximab and primary angioplasty for AMI.
Conclusion Abciximab + low dose tPA was effective in achieving TIMI 3 grade flow; primary angioplasty with stent + abciximab restored normal coronary flow.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.